Cassava Sciences Inc (SAVA)
26.48
-5.70
(-17.71%)
USD |
NASDAQ |
Nov 22, 16:00
26.62
+0.14
(+0.53%)
After-Hours: 20:00
Cassava Sciences Stock Buybacks (Quarterly)
Stock Buybacks (Quarterly) Chart
Historical Stock Buybacks (Quarterly) Data
Date | Value |
---|---|
December 31, 2021 | 0.692M |
September 30, 2021 | 0.00 |
June 30, 2021 | 0.00 |
March 31, 2021 | -190.52M |
December 31, 2020 | -70.61M |
September 30, 2020 | -4.584M |
June 30, 2020 | 0.00 |
March 31, 2020 | 0.00 |
December 31, 2019 | |
September 30, 2019 | |
June 30, 2019 | |
March 31, 2019 | |
December 31, 2018 | 0.072M |
September 30, 2018 | -12.27M |
June 30, 2018 | 0.00 |
March 31, 2018 | -1.898M |
December 31, 2017 | 0.00 |
September 30, 2017 | 0.00 |
June 30, 2017 | 0.00 |
March 31, 2017 | 0.00 |
December 31, 2016 | |
September 30, 2016 | |
June 30, 2016 | |
March 31, 2016 | |
December 31, 2015 |
Date | Value |
---|---|
September 30, 2015 | |
June 30, 2015 | |
March 31, 2015 | |
December 31, 2014 | 0.00 |
September 30, 2014 | 0.00 |
June 30, 2014 | -0.313M |
March 31, 2014 | -0.066M |
December 31, 2013 | -0.264M |
September 30, 2013 | 0.00 |
June 30, 2013 | -0.254M |
March 31, 2013 | -0.006M |
December 31, 2012 | 0.186M |
September 30, 2012 | 0.00 |
June 30, 2012 | -0.186M |
March 31, 2012 | 0.00 |
December 31, 2011 | -0.08M |
September 30, 2011 | -0.052M |
June 30, 2011 | -4.485M |
March 31, 2011 | -4.425M |
December 31, 2010 | -0.566M |
September 30, 2010 | -0.154M |
June 30, 2010 | -0.382M |
March 31, 2010 | -0.983M |
December 31, 2009 | -0.129M |
September 30, 2009 | -0.164M |
Stock Buyback Definition
Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.
Stock Buybacks (Quarterly) Range, Past 5 Years
-190.52M
Minimum
Mar 2021
0.692M
Maximum
Dec 2021
-33.13M
Average
--
Median
Mar 2020
Stock Buybacks (Quarterly) Benchmarks
Bristol-Myers Squibb Co | 0.00 |
Seelos Therapeutics Inc | -0.927M |
EyePoint Pharmaceuticals Inc | -11.79M |
PTC Therapeutics Inc | -- |
Adverum Biotechnologies Inc | 0.00 |